PDCD1 and colorectal carcinoma: Therefore, our results may provide a valuable resource for human T cell immunity in PDT therapeutic immunotherapies directed at the hPD-1/PD-L1 blockade in patients with CRC based on a comprehensive examination of the T cell immune profile in the TME.